ero.eular.org
@ero.eular.org
#EULAR2026 concludes today after 4 outstanding days in #London.

🎯From #AI and multi-omics to #CAR-T therapies and precision medicine, the innovation showcased this week highlights the strength of our global community.

See you next year in Berlin! 🇩🇪

#EULAR2026 #Rheumatology
June 6, 2026 at 5:54 PM
Last day of #EULAR2026 with interesting insights on strength training and RMDs.

🏋🏼‍♂️ Small amount of pain doesn’t mean joints are being damaged;

🏋🏼‍♂️ Essential to tailor the prescription;

🏋🏼‍♂️ Include patients in programme development
June 6, 2026 at 1:52 PM
Excellent overview by Raj Sengupta on early treatment in early #axSpA.

The accumulating evidence supports the importance of early diagnosis, early target attainment, and intervention during the window of opportunity to optimize long-term outcomes.

#EULAR2026
June 6, 2026 at 11:52 AM
🚨What if “stable” systemic sclerosis isn’t really stable? 🤔

👉Several posters at #EULAR2026 today have highlighted #hidden #progression and the importance of looking beyond baseline risk categories❗

#SystemicSclerosis #EULAR2026 #Rheumatology
June 5, 2026 at 5:27 PM
Such an interesting session today at #day3 of #EULAR2026 about Patient Education. Key messages:

🔑 Self-efficacy as an important outcome in the updated SLR

🔑 Theoretical frameworks should be used - patient activation as a new one

🔑 Valued outcomes + FUN + habit/identity = maintenance

MC
June 5, 2026 at 2:48 PM
Why do some auto-immune diseases affect in a different way women and men ❔
Interesting question on day3 of #EULAR26.
Answers for Large Vessel Vasculitis:
- inflammatory genes on sex chromosomes 🧬
- sex hormones ♀️♂️
- aging 👴🏻
- local vascular factors 🩸
@elvishysa.bsky.social
June 5, 2026 at 2:24 PM
Interesting session on the role of the microbiota in rheumatology practice.

A great reminder that HPR have an important role in supporting lifestyle, education and person-centred care alongside emerging scientific evidence.

#EULAR2026
@rafaprieto4.bsky.social
June 5, 2026 at 10:43 AM
Great session on implementation research in rheumatology yesterday in the EULAR Congress.

A timely reminder that evidence only creates impact when it reaches clinical practice and improves patient care

#EULAR2026
@rafaprieto4.bsky.social
June 5, 2026 at 10:37 AM
​"What if medical education could inspire people and not only inform them?"
​Brilliant presentation by @cristianasieiro.bsky.social on RheumaVision at #EULAR2026 in London. Community co-creation is the future! 🏥✨
June 5, 2026 at 10:29 AM
A very unique @EMEUNET session at #EULAR26
Gamification for education ⚽
Engagement is essential for education 🔑
Information is everywhere 💻
Experience helps remember information 🧠
June 5, 2026 at 9:41 AM
🔍 insights into the pathophysiology of PMR
With the rise of targeted therapies 🎯 it is important to better understand how it can impact disease mechanisms. OP0283 #EULAR26
Unrevealing the roles of synovial fibroblasts, IL-17A, IFNg and TH17 🧩
June 5, 2026 at 7:26 AM
Kicking off Day 3 of #EULAR2026 with an WIN plenary session on pregnancy and fertility management in patients living with RMDs.

Looking forward to the discussions and latest insights.
June 5, 2026 at 7:17 AM
Starting #day2 with emotional tears.

➡️ Edgar Stene Winner presented her emotional essay on hey journey with scleroderma.

➡️ Digestive symptoms are common in Sjögren patients;

➡️ Accomodation of people w/ chronic diseases is an investment

➡️ Asymmetry in access to LLM-based decision support

MC
June 4, 2026 at 2:33 PM
Today in the EULAR 2026 Congress we had the first EULAR HPR Move Together led by the experts Mariana Carvalho and Mikel Al Achek.

🔬An amazing way to do an evidence-based active break during the Congress.

🚨 Do not miss the session tomorrow!

#EULAR2026
@rafaprieto4.bsky.social
June 4, 2026 at 2:24 PM
Implementation in rheumatology : bringing evidence and practice
#EULAR2026
Implementation strategies turn change into action by addressing barriers, selecting the right approaches, and engaging diverse stakeholders to drive impact and adoption in real world: Are you ready to adopt implementation ?
June 4, 2026 at 2:22 PM
​📊 New data from the SPACE cohort evaluates the 2025 ASAS-SPARTAN #axSpA criteria!
​The revised sets prioritise specificity (💥 all >94% regardless of reader).
​📉 However, massive drop-off in sensitivity. For local readers, 83.0% (2009 criteria) down to just 60.2%. #EULAR2026 #OP0239
June 4, 2026 at 8:35 AM
Direct from #EULAR2026
▶️Perimenopause is associated with increased disease activity in PsA
▶️Rheumatologists should be aware of possible flares of PSA
during peri-menopause
➡️ Research is needed to understand the effect of sex-effect in different life stages of PsA
June 4, 2026 at 8:17 AM
Hope is still blowing in #SjögrensDisease at #EULAR26!
OP0160
TYK2 inhibition signature is shared in #SLE and #SjD 🔬
TYK2 inhibition signature is associated with disease activity 🔥
Let's wait for the results of the phase 3 trials of TYK inhibition in both diseases ⏳
June 4, 2026 at 8:12 AM
Influence of menopause status on disease activity and remission in RA: BIOPURE study
#EULAR2026
June 4, 2026 at 7:39 AM
Direct form #EULAR26, day 2:
Promising new therapeutic agent ❔
Among the large landscapes of CAR-T development:
✅ Dual targets (CD19, CD38)
✅ No conditioning chemotherapy
✅ Combination with mAB and T-cell engagers
➡️ Next step: phase 1 study
June 4, 2026 at 7:32 AM
Day 2 of EULAR 2026 is about to begin

Following a successful opening day, delegates are gathering for another full day of scientific sessions, expert insights, and engaging discussions.

Stay tuned for more highlights from #EULAR2026
June 4, 2026 at 7:07 AM
First #PARE session, and also first fishbowl session of #EULAR2026

Several topics were discussed, highlighting:

✅ Engaging young people from early stages

✅ Creating trustful places to find information

✅ Find the unmet needs across countries

✅ Collaboration between communities is essential
June 3, 2026 at 5:13 PM
First debate from #EULAR26 🫯
Should polymyalgia rheumatica be managed by GPs or rheumatologist ❓
After a first round of talks, 80% of the audience is convinced that rheumatologist should managed PMR. 📊
June 3, 2026 at 2:09 PM
🚀 #EULAR2026 starts with a #capillaroscopy challenge!

❓Which statement is #NOT correct?

🎯A great reminder that isolated capillary abnormalities may also be seen in healthy individuals. Context matters. 🔬

#Capillaroscopy #Rheumatology
June 3, 2026 at 1:50 PM
Sitting in on the WIN Psoriatic Arthritis plenary session right now! 🩺✨
​Fascinating presentation on stage from Dennis McGonagle diving into new data on how Lipopolysaccharide + JAK inhibition increases clot formation in vitro in RA 🧬📊.
June 3, 2026 at 1:47 PM